Mark Guttman - Concepedia

Author

Mark Guttman

Also Known As

E. Cubo, Guttman, M., Guttman, Mark, M Guttman, M Reese Guttman, M. Guttman, M. R. GUTTMAN, M. R. Guttman, M. REESE GUTTMAN, M. Reese Guttman

200

Publications

11.7K

Citations

H-Index

163

Concepts

All Affiliations

University of Toronto Centre for Addiction and Mental Health Centre for Movement Disorders University of British Columbia Cleveland Clinic

About

Mark Guttman is an author at University of Toronto specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	45	3.4K
2	Health Sciences	3	3	129
3	Education	2	2	26
4	Engineering	2	2	189
5	Nursing	2	2	22

Mark Guttman

110

Publications

9.8K

Citations

H-Index

Page 1

	Year	Citations
Detection of Huntington's disease decades before diagnosis: the Predict-HD study Jane S. Paulsen, Douglas R. Langbehn, Julie C. Stout, Journal of Neurology Neurosurgery & Psychiatry	2007	804
Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease Stephen J. Kish, Junchao Tong, Oleh Hornykiewicz, Brain NeurotransmitterCaudate Versus PutamenSocial SciencesSerotonin MarkersNeurology	2007	377
Adenosine A <sub>2A</sub> receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005) Peter A. LeWitt, Mark Guttman, James W. Tetrud, Annals of Neurology	2008	346
Identification of motor and nonmotor wearing‐off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment Mark Stacy, A Bowron, Mark Guttman, Movement Disorders	2005	238
Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease Julie M. Wilson, Allan I. Levey, Ali H. Rajput, Neurology Terminal LossIdiopathic ParkinsonDifferent DopamineNeuroanatomyParkinson Disease	1996	217
Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease Mark Guttman Neurology	1997	211
Clinical markers of early disease in persons near onset of Huntington’s disease Jane S. Paulsen, Hongqing Zhao, Julie C. Stout, Neurology	2001	205
Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders Junchao Tong, Gausiha Rathitharan, Jeffrey H. Meyer, Brain	2017	202
Brain α-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation Junchao Tong, Henry Wong, Mark Guttman, Brain	2009	198
Thalamic metabolism and symptom onset in preclinical Huntington's disease Andrew Feigin, Chengke Tang, Yilong Ma, Brain	2007	195

Page 1